Research programme: micacocidin analogues - Shionogi
Alternative Names: Micacocidin analogues research programme - ShionogiLatest Information Update: 09 Jul 2002
At a glance
- Originator Shionogi
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoplasma infections
Most Recent Events
- 09 Jul 2002 Discontinued - Preclinical for Mycoplasma infections in Japan (unspecified route)
- 17 Oct 2001 Preclinical development for Mycoplasma infections in Japan (Unknown route)